These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 16927822

  • 1. [Mechanism of oral absorption of panaxnotoginseng saponins].
    Han M, Han LM, Wang QS, Bai ZH, Fang XL.
    Yao Xue Xue Bao; 2006 Jun; 41(6):498-505. PubMed ID: 16927822
    [Abstract] [Full Text] [Related]

  • 2. Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models.
    Han M, Fang XL.
    Acta Pharmacol Sin; 2006 Apr; 27(4):499-505. PubMed ID: 16539852
    [Abstract] [Full Text] [Related]

  • 3. Oral absorption of ginsenoside Rb1 using in vitro and in vivo models.
    Han M, Sha X, Wu Y, Fang X.
    Planta Med; 2006 Apr; 72(5):398-404. PubMed ID: 16557452
    [Abstract] [Full Text] [Related]

  • 4. [Comparison between the characteristics of absorption and pharmacokinetic behavior of ginsenoside Rg1 and ginsenoside Rb, of Panax notoginseng saponins].
    Han M, Fu S, Fang XL.
    Yao Xue Xue Bao; 2007 Aug; 42(8):849-53. PubMed ID: 17944233
    [Abstract] [Full Text] [Related]

  • 5. Self-micelle formation and the incorporation of lipid in the formulation affect the intestinal absorption of Panax notoginseng.
    Xiong J, Guo J, Huang L, Meng B, Ping Q.
    Int J Pharm; 2008 Aug 06; 360(1-2):191-6. PubMed ID: 18502060
    [Abstract] [Full Text] [Related]

  • 6. [In vivo distribution and pharmacokinetics of multiple effective components contained in Panax notoginseng saponins after intratympanic administration].
    Chen G, Mu L, Zhang X, Hou S, Nan H.
    Zhongguo Zhong Yao Za Zhi; 2011 Jul 06; 36(13):1815-20. PubMed ID: 22032151
    [Abstract] [Full Text] [Related]

  • 7. The use of lipid-based formulations to increase the oral bioavailability of Panax notoginseng saponins following a single oral gavage to rats.
    Xiong J, Guo J, Huang L, Meng B, Ping Q.
    Drug Dev Ind Pharm; 2008 Jan 06; 34(1):65-72. PubMed ID: 18214757
    [Abstract] [Full Text] [Related]

  • 8. [In vitro balanced sustained-release of Panax notoginseng saponins controlled with various matrix materials].
    Zhou X, Fu CM, He Y, Zhang JM, Liu HY.
    Yao Xue Xue Bao; 2010 Apr 06; 45(4):505-9. PubMed ID: 21355219
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combined Contribution of Increased Intestinal Permeability and Inhibited Deglycosylation of Ginsenoside Rb1 in the Intestinal Tract to the Enhancement of Ginsenoside Rb1 Exposure in Diabetic Rats after Oral Administration.
    Liu C, Hu M, Guo H, Zhang M, Zhang J, Li F, Zhong Z, Chen Y, Li Y, Xu P, Li J, Liu L, Liu X.
    Drug Metab Dispos; 2015 Nov 06; 43(11):1702-10. PubMed ID: 26265741
    [Abstract] [Full Text] [Related]

  • 11. [Studies on influence factors of gnsenoside Rg1 and Rb1 absorption in intestines of rats].
    Li W, Nan L, Ji Y, Sun X, Sun Z.
    Zhongguo Zhong Yao Za Zhi; 2009 Oct 06; 34(20):2627-32. PubMed ID: 20069908
    [Abstract] [Full Text] [Related]

  • 12. [Studies on the pharmacodynamics of ginsenoside-Rg1, -Rb1 and -Rb2 in rats].
    Takino Y.
    Yakugaku Zasshi; 1994 Aug 06; 114(8):550-64. PubMed ID: 7932100
    [Abstract] [Full Text] [Related]

  • 13. [Screening of Panax notoginsenoside water in oil microemulsion formulations and their evaluation in vitro and in vivo].
    Han M, Fu S, Fang XL.
    Yao Xue Xue Bao; 2007 Jul 06; 42(7):780-6. PubMed ID: 17882965
    [Abstract] [Full Text] [Related]

  • 14. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.
    Fan J, Liu D, He C, Li X, He F.
    J Ethnopharmacol; 2016 Nov 04; 192():423-430. PubMed ID: 27620662
    [Abstract] [Full Text] [Related]

  • 15. A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats.
    Zhan S, Guo W, Shao Q, Fan X, Li Z, Cheng Y.
    J Ethnopharmacol; 2014 Mar 14; 152(2):333-9. PubMed ID: 24462784
    [Abstract] [Full Text] [Related]

  • 16. Active absorption of ginsenoside Rg1 in vitro and in vivo: the role of sodium-dependent glucose co-transporter 1.
    Xiong J, Sun M, Guo J, Huang L, Wang S, Meng B, Ping Q.
    J Pharm Pharmacol; 2009 Mar 14; 61(3):381-6. PubMed ID: 19222912
    [Abstract] [Full Text] [Related]

  • 17. Preparation Procedure and Pharmacokinetic Study of Water-in-Oil Nanoemulsion of Panax Notoginseng Saponins for Improving the Oral Bioavailability.
    Liu Z, Zhang Q, Ding L, Li C, Yin Z, Yan G, Pi J, Li J, Li N, Qi D.
    Curr Drug Deliv; 2016 Mar 14; 13(4):600-10. PubMed ID: 26051185
    [Abstract] [Full Text] [Related]

  • 18. Absorption profiles of sanchinoside R1 and ginsenoside Rg1 in the rat intestine.
    Liang F, Hua JX.
    Eur J Drug Metab Pharmacokinet; 2005 Mar 14; 30(4):261-8. PubMed ID: 16435571
    [Abstract] [Full Text] [Related]

  • 19. Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism.
    Shen H, Gao XJ, Li T, Jing WH, Han BL, Jia YM, Hu N, Yan ZX, Li SL, Yan R.
    J Ethnopharmacol; 2018 Apr 24; 216():47-56. PubMed ID: 29366768
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacokinetics of ginsenosides Rg1 and its metabolites in rats].
    Feng L, Hu CJ, Yu LY.
    Yao Xue Xue Bao; 2010 May 24; 45(5):636-40. PubMed ID: 20931768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.